Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rang în acțiuni #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Preț acțiune
$0.873
Capitalizare de piață
$257.19M
Schimbare (1 zi)
-0.78%
Schimbare (1 an)
-15.24%
Țară
US
Tranzacționează Invivyd, Inc. (IVVD)

Categorie

Istoric al prețului acțiunii pentru Invivyd, Inc. (IVVD)
Cel mai mare preț de închidere: $0.85 pe 2026-09-01

Cel mai mic preț de închidere: $27.68 pe 2021-08-01
Istoric al prețului acțiunii pentru Invivyd, Inc. din 2021 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -37.40%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$550.65 37.32%
US
$1.05K 48.27%
NL
$148.50 513.89%
US
$122.21 -10.03%
AU
$763.69 9.05%
CH